SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Histogen Inc. (HSTO) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 46/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HSTO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.46
Book Value / Share$0.00
Revenue / Share$1.17
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-2.12 |
$0.00 |
$-15.62M |
- |
| 2014 |
$-1.44 |
$0.00 |
$-22.32M |
- |
| 2015 |
$-1.30 |
$0.00 |
$-24.15M |
- |
| 2016 |
$-262.55 |
$799.05K |
$-29.73M |
-3721.1% |
| 2017 |
$-121.71 |
$35.38M |
$-17.4M |
-49.2% |
| 2018 |
$-118.60 |
$33.59M |
$-18.01M |
-53.6% |
| 2019 |
$-5.02 |
$11.45M |
$-11.39M |
-99.4% |
| 2020 |
$-41.60 |
$2.06M |
$-18.77M |
-911.6% |
| 2021 |
$-7.51 |
$919K |
$-14.95M |
-1626.8% |
| 2022 |
$-3.46 |
$3.77M |
$-10.62M |
-281.8% |
